Immediate Corticosteroid Therapy and Rituximab to Prevent Generalization in Ocular Myasthenia: a PROBE Multicenter Open-label Randomized Controlled Trial.
Clinical trial NCT06342544 · RECRUITING
Trial details
- NCT number
- NCT06342544
- Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-29
- Primary completion
- 2028-06-01
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.